Literature DB >> 20103670

Nuclear factor-kappaB and tumor-associated macrophages.

Alessandra Mancino1, Toby Lawrence.   

Abstract

Tumor-associated macrophages (TAM) have been linked with the progression of cancer by favoring tumor angiogenesis, growth, and metastasis. The precise mechanisms that maintain the protumor phenotype of TAM are poorly understood, but recent research has highlighted a number of signaling pathways that are important in TAM phenotype and function. Nuclear factor-kappaB (NF-kappaB) is considered the master regulator of inflammatory and immune responses. Recently several genetic studies have indicated NF-kappaB is an important pathway in TAM for the integration of signals from the tumor microenvironment that promote carcinogenesis. This review will focus on the role of NF-kappaB in TAM and the potential of targeting this pathway as a novel therapeutic strategy against cancer.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20103670      PMCID: PMC6485421          DOI: 10.1158/1078-0432.CCR-09-1015

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  59 in total

1.  Intratumoral mediated immunosuppression is prognostic in genetically engineered murine models of glioma and correlates to immunotherapeutic responses.

Authors:  Ling-Yuan Kong; Adam S Wu; Tiffany Doucette; Jun Wei; Waldemar Priebe; Gregory N Fuller; Wei Qiao; Raymond Sawaya; Ganesh Rao; Amy B Heimberger
Journal:  Clin Cancer Res       Date:  2010-10-04       Impact factor: 12.531

2.  Antitumor effect of Batf2 through IL-12 p40 up-regulation in tumor-associated macrophages.

Authors:  Hisashi Kanemaru; Fumihiro Yamane; Kiyoharu Fukushima; Takanori Matsuki; Takahiro Kawasaki; Isao Ebina; Kanako Kuniyoshi; Hiroki Tanaka; Kenta Maruyama; Kazuhiko Maeda; Takashi Satoh; Shizuo Akira
Journal:  Proc Natl Acad Sci U S A       Date:  2017-08-14       Impact factor: 11.205

Review 3.  Macrophages are important mediators of either tumor- or inflammation-induced lymphangiogenesis.

Authors:  Rui-Cheng Ji
Journal:  Cell Mol Life Sci       Date:  2011-10-08       Impact factor: 9.261

4.  CCL18 from tumor-associated macrophages promotes breast cancer metastasis via PITPNM3.

Authors:  Jingqi Chen; Yandan Yao; Chang Gong; Fengyan Yu; Shicheng Su; Jianing Chen; Bodu Liu; Hui Deng; Fengsong Wang; Ling Lin; Herui Yao; Fengxi Su; Karen S Anderson; Qiang Liu; Mark E Ewen; Xuebiao Yao; Erwei Song
Journal:  Cancer Cell       Date:  2011-04-12       Impact factor: 31.743

5.  Serum interleukin-33 levels in patients with gastric cancer.

Authors:  Pinghu Sun; Qiwen Ben; Shuiping Tu; Wenjie Dong; Xiaoguang Qi; Yunlin Wu
Journal:  Dig Dis Sci       Date:  2011-06-04       Impact factor: 3.199

Review 6.  Immune therapeutic targeting of glioma cancer stem cells.

Authors:  Mustafa Aziz Hatiboglu; Jun Wei; Adam Sauh Gee Wu; Amy B Heimberger
Journal:  Target Oncol       Date:  2010-08-25       Impact factor: 4.493

7.  The Critical Role of Proteolytic Relay through Cathepsins B and E in the Phenotypic Change of Microglia/Macrophage.

Authors:  Junjun Ni; Zhou Wu; Christoph Peterts; Kenji Yamamoto; Hong Qing; Hiroshi Nakanishi
Journal:  J Neurosci       Date:  2015-09-09       Impact factor: 6.167

8.  NFκB signaling regulates embryonic and adult neurogenesis.

Authors:  Yonggang Zhang; Wenhui Hu
Journal:  Front Biol (Beijing)       Date:  2012-08

9.  Extracellular HSP110 skews macrophage polarization in colorectal cancer.

Authors:  Kevin Berthenet; Christophe Boudesco; Ada Collura; Magali Svrcek; Sarah Richaud; Arlette Hammann; Sebastien Causse; Nadhir Yousfi; Kristell Wanherdrick; Laurence Duplomb; Alex Duval; Carmen Garrido; Gaetan Jego
Journal:  Oncoimmunology       Date:  2016-04-22       Impact factor: 8.110

10.  Anti-Jagged Immunotherapy Inhibits MDSCs and Overcomes Tumor-Induced Tolerance.

Authors:  Rosa A Sierra; Jimena Trillo-Tinoco; Eslam Mohamed; Lolie Yu; Bhagelu R Achyut; Ali Arbab; Jennifer W Bradford; Barbara A Osborne; Lucio Miele; Paulo C Rodriguez
Journal:  Cancer Res       Date:  2017-09-13       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.